Renalytix (RENX) Stock Chart & Stock Price History GBX 5.88 +0.13 (+2.26%) As of 08/22/2025 12:05 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Renalytix Stock Price Performance The Renalytix (RENX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 44.97%, with a year-to-date return of -46.55%. In the past month, the stock has decreased 21.60%, reflecting recent market activity. As of the latest close, Renalytix traded at GBX 5.88 with a market cap of £24.37 million and volume of 68,736 shares. Five years ago, the stock traded at GBX 565, representing a 98.96% decrease over that period. At the time, it had a market cap of £406.97 million and a volume of 11,561 shares. Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.00%1 Month Performance-21.60%3 Month Performance-21.60%Year-To-Date Performance-46.55%1 Year Performance-44.97%5 Year Performance-98.96% RENX Stock Chart for Saturday, August, 23, 2025 RENX Chart by TradingView Renalytix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025GBX 5.62GBX 5.88+4.72%GBX 6GBX 5.5068,736 shs£24.37 million08/21/2025GBX 5.80GBX 5.62-3.19%GBX 5.78GBX 5.6217,367 shs£23.28 million08/20/2025GBX 5.88GBX 5.80-1.36%GBX 5.86GBX 5.62109,819 shs£24.04 million08/19/2025GBX 5.60GBX 5.88+5.00%GBX 6GBX 5.5062,754 shs£24.37 million08/18/2025GBX 5.99GBX 5.60-6.51%GBX 6GBX 5.5034,159 shs£23.21 million08/15/2025GBX 5.92GBX 5.99+1.18%GBX 6GBX 5.51238,323 shs£24.83 million08/14/2025GBX 5.97GBX 5.92-0.80%GBX 6GBX 5.55118,356 shs£24.54 million08/13/2025GBX 6.10GBX 5.97-2.16%GBX 6.50GBX 5.62354,768 shs£24.74 million08/12/2025GBX 7GBX 6.10-12.86%GBX 8GBX 6.10480,838 shs£25.29 million08/11/2025GBX 7.10GBX 7-1.41%GBX 8GBX 717,084 shs£29.02 million Get the Latest News and Ratings for RENX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025GBX 7GBX 7.10+1.43%GBX 8GBX 7.10111,508 shs£29.43 million08/07/2025GBX 7.50GBX 7-6.67%GBX 7.40GBX 781,156 shs£29.02 million08/06/2025GBX 7.50GBX 7.50GBX 8GBX 7187,072 shs£31.09 million08/05/2025GBX 7.15GBX 7.50+4.90%GBX 8GBX 7.2060,552 shs£31.09 million08/04/2025GBX 7.53GBX 7.15-5.05%GBX 7.15GBX 740,105 shs£29.64 million08/01/2025GBX 8GBX 7.53-5.88%GBX 7.55GBX 7.1069,208 shs£31.21 million07/31/2025GBX 8GBX 8GBX 8GBX 7.153,856 shs£33.16 million07/30/2025GBX 7.50GBX 8+6.67%GBX 8GBX 7152,208 shs£33.16 million07/29/2025GBX 7.10GBX 7.50+5.63%GBX 8GBX 7.10183,953 shs£31.09 million07/28/2025GBX 7.13GBX 7.10-0.38%GBX 7.50GBX 794,868 shs£29.43 million07/25/2025GBX 7.13GBX 7.13GBX 7.13GBX 747,547 shs£29.54 million07/24/2025GBX 7.50GBX 7.13-4.97%GBX 7.13GBX 739,751 shs£29.54 million07/23/2025GBX 7.13GBX 7.50+5.26%GBX 7.50GBX 739,823 shs£31.09 million07/22/2025GBX 7.50GBX 7.13-5.00%GBX 7.25GBX 7.1361,853 shs£29.54 million Related Companies Kooth Stock Chart Cambridge Cognition Stock Chart Induction Healthcare Group Stock Chart Feedback Stock Chart IQ-AI Stock Chart Trellus Health Stock Chart Craneware Stock Chart BATM Advanced Communications Stock Chart Venture Life Group Stock Chart Shield Therapeutics Stock Chart Receive RENX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. This page (LON:RENX) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Renalytix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access